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A B S T R A C T   
Searching for new natural bioactive capping agents represent an urgent priority in the green synthesis of metal 
nanoparticles. Additionaly, the biosaftey of metal nanparticles is a major concern especially in medical appli-
cations. Recently, the use of pharmacollogicaly active natural products as capping agents has been deployed to 
avoid toxic effects during the nanoparticles preparation and to enhance their drugability compared with con-
vential drugs. Helichrysum foetidum is a South African medicinal plant used in folk medicine for the treatment of 
different human pathologies, and it is known to contain a variety of bioactive compounds. Herein, the total 
extract and two pure chalcones, helichrysetin and helichrysin, isolated from the same plant were successfully 
used to synthesize quasi-monodispersed gold nanoparticles in the size range of 2–12 nm. The bio-evaluation of 
samples indicated that the AuNP/capping agent conjugates are biostable, and have different biological profiles 
from the total extract/pure compounds. The enzymatic inhibition assays showed significant inhibition by the 
total extract, helichrysetin and their gold nanoparticles. Interestingly, a similar activity was observed for glucose 
uptake in HEK293 treated cells. On the other hand, all the tested samples relatively demonstrated no cytotoxicity 
when tested against the HaCaT keratinocytes. In conclusion, the study demonstrated potential enhancement of 
glucose uptake in mammalian kidney cells, and inhibition of carbohydrate-hydrolysing enzymes by green syn-
thesized gold nanoparticles of H. foetidum. It also provides a therapeutic appraisal of AuNPs/chalcones conjugate 
towards the development of antidiabetes drugs derived from H. foetidum and its gold nanoparticles.   
1. Introduction 
Polyphenols, aromaticity and conjugated systems are characteristic 
of plant-based flavonoids which account for their numerous roles. These 
properties have been shown to exert influence on the interface between 
the flavonoids and cell membranes during bio evaluation as antioxi-
dants, cytotoxicity and stress-related diseases such as diabetes and 
overweight [29,35]. Carbohydrate metabolism requires α-glucosidase 
and α-amylase enzymes secreted in the small intestine to hydrolyse 
glycoside bonds from complex carbohydrate foods at different points to 
produce α-glucose as the product. Uncontrolled activities of these en-
zymes increase postprandial glucose that leads to an imbalance between 
glucose absorption in the bloodstream and insulin secretion for glucose 
uptake [21]. Inhibition of activities of α-glucosidase and α-amylase en-
zymes have been reported to reduce the risk of obesity, kidney failure 
and cardiovascular diseases during Type-2 diabetic (T2D) management 
[11]. Acarbose, voglibose, miglitol and metfomin are conventional 
antidiabetic drugs commonly prescribed to inhibit hepatic glucose 
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production due to the breakdown of carbohydrate by α-glucosidase and 
α -amylase enzymes [2]. However, due to the potential side effect of 
increasing gas build up in the intestine and liver toxicity on prolong 
usage [9], there is a need for the evaluation of alternative drugs in the 
nano range. Hence, it has become necessary to consider α-glucosidase 
and amylase inhibition drugs from natural products. 
Helichrysum species, also known as everlasting flowers, are widely 
distributed in the Southern hemisphere of Africa, Europe and Australia 
[4]. They are valued as medicinal plants for the treatment of ailments 
such as influenza, eye infection, kidney stones, relief from 
gastrointestinal disorders, menstrual pain, headache, wound-healing, 
inflammation and to induce trance [22,32]. Previous studies of the 
phytochemicals from H. foetidum demonstrated antioxidants, antimi-
crobial and protease-inhibiting activities [5,26,27,34]. Apart from 
kaur-16-en-18-oic, these phytochemicals were mostly chalcones and 
flavonoids (helichrysetin and its glycoside, helichrysin, apigenin and its 
glycoside and 7,4′-dihydroxy-5-methoxy-flavanone), which are known 
to have antioxidant properties, and could counteract glucose-induced 
oxidative stress [18,19,26]. Furthermore, several studies have shown a 
dual role of flavonoids compounds with antidiabetic potential [30] and 
Fig. 1. Compounds A and B isolated from polar fractions of H. foetidum.  
Fig. 2. Proposed interaction of the isolated compounds (capping agents) at the surface of gold nanoparticle.  
Fig. 3. UV-Vis spectra for the synthesized HF, HA and HB gold nanoparticles.  
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as reducing agents in the formation of gold nanoparticles [6,14,28]. 
Among other metal nanoparticles, gold nanoparticles are increasingly 
being used in biomedicine and therapeutics due to their large surface 
area, biocompatibility and ease to be functionalized with biomolecules 
for active drug delivery [25,31]. This property of gold nanoparticles 
may help to overcome the possible removal of drugs from the systemic 
circulation by activities of the spleen and the liver. The synthesis of 
functionalized gold nanoparticles using total extracts of Cassia auriculate 
for treatment of diabetes mellitus has been previously reported [36]. 
However, the use of pure compounds could give a better understanding 
of the mechanism of formation and surface interface of 
flavonoid-mediated metallic nanoparticles [3,33,38]. 
Hence, in this report, the green synthesis of gold nanoparticle via H. 
foetidum total extract and its isolated pure compounds is presented. The 
total extract, the isolates and the biosynthesized gold nanoparticles were 
characterized, and evaluated in vitro for glucose uptake and cytotoxicity. 
To the best of our knowledge, this is the first study to report the green 
synthesis of gold nanoparticles via H. foetidum constituents, and to 
evaluate their potential use in the management of diabetes. 
2. Materials and methods 
2.1. Plant material 
Helichrysum foetidum was collected from Worcester in November 
2018 and identified by Professor Cupido, department of Botany, Fort 
Hare University, South Africa. The fresh plant materials were left to dry 
in shade for four weeks before extraction. 
2.2. Chemicals and reagents 
All chemicals were analytical grade. Methanol, hexane, dichloro-
methane, ethanol, acetone, ethyl acetate, sodium hydroxide and sodium 
chloride were purchased from Science World Chemicals, South Africa. 
Fig. 4. a: (i) HR-TEM (ii) SAED (iii) size distribution histogram of HF-AuNPs 
b: (i) HR-TEM (ii) SAED (iii) size distribution histogram of compound A-AuNPs 
c: (i) HR-TEM (ii) SAED (iii) size distribution histogram of compound B-AuNPs. 
A.A. Omolaja et al.                                                                                                                                                                                                                             
Surfaces and Interfaces 25 (2021) 101251
4
Sodium tetrachloroaurate (III) dihydrate (Na2AuCl4.2H2O, 99.99%) was 
purchased from BDH Chemical Limited England. Silica gel 60 (0.063- 
0.200 mm) and Sephadex (LH-20) were supplied by Merck (Darmstadt, 
Germany) and Sigma-Aldrich (Cape Town, WC, South Africa) respec-
tively. Cysteine, glycine, bovine serum albumin (BSA), α-glucosidase 
(Saccharomyces cerevisiae), 4-nitrophenyl α-D-glucopyranoside (P-NPG), 
and 3,5-dinitro salicylic acid (DNS) were purchased from Sigma-Aldrich 
(St. Louis, MO United States). The NMR spectra were recorded on an 
Avance 400 MHz NMR spectrometer (Bruker, Rheinstetten, Germany) in 
deuterated acetone. Milli-Q de-ionized water was produced in-house 
(18.2 MΩ•cm at 25◦C), was used. 
2.3. Cell culture and treatment 
Renocytes (HEK293 kidney cells) were obtained from the American 
Type Culture Collection (Manassas, VA, USA), and were cultured in 
DMEM containing essential amino acids, sodium pyruvate and L-gluta-
mine. Cell seeding was done on 24-well plates (50 000 cells/well) for the 
2-deoxy-[3H]-D-glucose assay (Promega, Madison, WI, USA). The 
HaCaT keratinocyte cell line from the human skin was a generous 
donation by the Mintek Laboratory, Department of Biotechnology, 
University of the Western Cape. Cells were cultured in monolayer using 
Dulbeco Modified Eagles Medium (DMEM, Lonza Group Ltd., Verviers, 
Belgium) supplemented with 10% foetal bovine serum (FBS, Gibco, Life 
Technologies Corporation, Paisley, UK) and 1% 100 U/mL penicillin and 
100 μg/mL (Lonza Group Ltd. Verviers, Belgium). Cells were grown at 
37◦C, in a humidified atmosphere consisting of 5% CO2 and 95% air. All 
cell culture media were routinely replaced every two to three days and 
were subcultured when they attained 80% confluency using a solution of 
0.25 % trypsin EDTA (Lonza Group Ltd., Verviers, Belgium). Myco-
plasma test was also conducted at intervals and only cells that were 
mycoplasma free were used for experiments. 
Fig. 5. i: Representative Zeta potential of compound A-AuNPs 
ii: Representative Zeta potential of compound B-AuNPs. 
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For treatment, a 1 mg/mL stock solution of extract, compounds and 
nanoparticles was prepared in distilled water and further dilutions were 
made in cell growth medium to obtain final concentrations of 20, 40, 60 
80 and 100 µg/mL used for the treatment. 
3. Experimental 
3.1. Extraction, isolation and characterization of compounds 
Air-dried leaves and flowers of H. foetidum weighing 620 g were 
chopped, coarsely powdered and completely extracted with methanol (5 
litres) for 48 hours at room temperature. The supernatant liquid was 
carefully decanted, filtered and concentrated. A dried dark yellowish 
crude extract (79.87 g) was obtained. The crude extract was fractionated 
by silica gel column (40 × 8 cm) chromatography using a solvent 
gradient system in order of increase polarity using hexane and ethyl 
acetate. Fractions of 500 mL were collected, and similar fractions were 
further combined to 18 sub-fractions labelled F1 - F18 based on simi-
larities of TLC profiles. Successive column chromatography of F9 and 
F16 lead to the isolation of two compounds; helichrysetin (compound B) 
and helichrysin (compound A) and their structures were characterized 
based on the analysis of their 1D and 2D NMR. 
Spectroscopic data of compounds A and B 
Compound A; Helichrysin (6`-methoxy-2`,4-dihydroxy-chalcone- 
4`-O-β-D-glucopyranoside): 1H NMR (400 MHz, acetone-d6): δH 7.88 
(1H, d, J = 15.6 Hz, Hα), 7.77 (1H, d, J = 15.6 Hz, Hβ), 7.62 (2H,d, J =
8.4 Hz, H2`), 6.93 (2H, d, J = 8.0 Hz, H3`), 6.30 (1H, d, J = 2.4 Hz, H3), 
6.21 (1H, d, J = 2.0 Hz, H5), glucose moiety; 5.13 (1H, d, J = 7.6 Hz, 
H1``), complex signals from 3.49 – 3.98 for H-2``- H-6``, 4.02 (3H, s, 
OMe). 13C NMR (100 MHz, acetone-d6): δC 193.7 (C=O), 168.3 (C4), 
165.0 (C-2), 97.7 (C-3), 92.9 (C-5), 163.7 (C-6), 161 (C-4`), 144.1 (Cβ), 
131.5 (C-2`), 127.8 (C-1`), 124.9 (Cα), 116.9 (C-3`), 107.8 (C-1), 56.64 
(OMe), glucose moiety; 101.00 (C-1``), 78.1 (C-5``), 77.9 (C-3``), 74.5 
(C-2``), 71.3 (C-4``), 62.6 (C-6``). 
Compound B; Helichrysetin (6`-methoxy-2`,4, 4`-trihydroxy-chal-
cone): 1H NMR (400 MHz, acetone-d6): δH 7.88 (1H, d, J = 15.6 Hz, 
Hα), 7.74 (1H, d, J = 15.6 Hz, Hβ), 7.61 (2H, d, J = 8.4 Hz, H-2`, -6`), 
6.93 (2H, d, J = 8.0 Hz, H-3`,-5`), 6.09 (1H, s, H-5), 6.02 (1H, s, H-3), 
3.98 (3H, s, OMe). 13C NMR (100 MHz, acetone-d6): δC 193.2 (C=O), 
168.5 (C-2), 165.7 (C-4), 164.3 (C-6), 143.3 (Cβ), 131.3 (C-6`), 128.0 (C- 
1`), 125.3 (Cα), 116.8 (C-3`), 106.3 (C-1), 96.9 (C-3), 92.2 (C-5), 56.41 
(OMe). 
Total extract and representative fractions were then screened for 
glucosidase and amylase enzymes inhibition and formation of AuNPs. 
3.2. Synthesis of gold nanoparticles 
The crude extract (HF) and isolated compounds A and B were 
screened for green synthesis of gold nanoparticles as reducing agents, at 
different concentrations in a 96-well microplate for determination of the 
optimum concentrations and the ratio of reducing agent to the gold 
precursor for further upscaling. 20 mg each of HF, compounds A and B 
were dissolved separately in 2 mL of de-ionized water, vortexed for 5 
minutes to obtain homogeneous solutions and then added dropwise to 
50 mL 1% w/w of sodium chloroaurate (III) solution at 90 ◦C for 40 
minutes under continuous stirring. An instantaneous colour change was 
observed from pale yellow to ruby red for HF and compound A. The ruby 
red colour appeared after 25 minutes for compound B suggesting the 
formation of gold nanoparticles for all samples. 
3.3. Characterization of gold nanoparticles 
Different characterization techniques such as UV, HR-TEM, XRD, 
FTIR, and dynamic light scattering (DLS) were used to investigate the 
formation of gold nanoparticles and their various physicochemical 
properties. The absorption bands due to electrons confined on the 
nanogold particles surface were measured with SPECTROstar Nano 
(BMG LABTECH, Germany) 2450 UV-vis spectrophotometer. 
The potential stability of the gold nanoparticles was determined 
through zeta potential measurement and the presence of inter-particle 
interaction from polydispersity indices (PDI), using a Zetasizer Nanos-
eries ZS90, model number ZEN3690 (Malvern Instruments Ltd, UK). To 
determine the hydrodynamic size, gold nanoparticles were diluted in de- 
ionized water in a volume ratio of 2:1. The zeta potential value gives an 
indication of the magnitude of repulsion between particles, which is 
suggestive of the stability of the colloidal system while the PDI gives the 
size distribution of the particles. 
High-Resolution Scanning Electron Microscope (HR-TEM) micro-
graphs were recorded on an FEI Tecnai G2 F20 S-Twin HRTEM, operated 
at 200 kV. A drop of the aqueous gold suspension was dropped on a 
carbon-coated copper grid and allowed to dry completely for an hour at 
room temperature. X-ray diffraction (Model Bruker AXS D8 advance 
with radiation at λkCukα1 = 1.5406 Å) was used to observe the crys-
tallinity of the particles. Measurements were performed using a multi-
purpose X-ray diffractometer D8-Advance from Bruker operated in a 
continuous θ-θ scan in locked coupled mode with Cu-Kα radiation. The 
sample was mounted in the centre of the sample holder on a glass slide 
and levelled up to the correct height. The measurements were performed 
within a range in 2θ between 30◦-80◦ with a typical step size of 0.034◦ in 
2θ. A position-sensitive detector, Lyn-Eye, was used to record diffraction 
data at a typical speed of 0.5 sec/step which is equivalent to an effective 
time of 92 sec/step for a scintillation counter. Analysis of HR-TEM and 
XRD images were carried out with ImageJ software, 1.50b version 
1.8.0_60 (http://imagej.nih.gov/ij) and Origin pro-2019 (64 bits) soft-
ware respectively. Vibrational bands of possible functional groups 
involved in the synthesis were recorded on a PerkinElmer Fourier- 
Transform Infrared Spectrometer 2000, equipped with a universal 
Fig. 6. X-ray diffractograms (Scintage instrument) collected from a single 
crystal of compound B-AuNPs, Compound A-AuNPs and HFAuNPs. 
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ATR-FTIR (PerkinElmer Spectrum 100, Llantrisant, Wales, UK) at 
transmission mode of 400 – 4000 cm− 1. 
3.4. In vitro stability study 
The in-vitro stability test was carried out by mixing 200 μL of gold 
nanoparticles solution with 100 μL biogenic amino acids (such as 0.5% 
Glycine, 0.5% BSA), phosphate buffer saline (PBS at pH 7 and pH 9) and 
1% NaCl solution in a 96-well plate and incubated (at 37◦C) for different 
periods. The stability of HF-AuNPs, Compound A-AuNPs and Compound 
B-AuNPs in these media were monitored with UV-Vis at an interval of 24 
hours for three days, for correlation of their respective maximum 
wavelengths with that of their synthesized gold nanoparticles. 
3.5. Enzymatic inhibition bioassay 
The inhibition potentials of α-glucosidase and α-amylase for HF, 
Compounds A, Compound B and their respective gold nanoparticles 
were carried out with slight modification of Badeggi et al. [3]. The 
samples were initially dissolved in methanol at 1 mg/mL as stock so-
lution respectively. A 96-well plate was set up for the reaction followed 
by a step-by-step pipetting of samples, buffer solution, enzymes and 
substrates. 50 μL phosphate buffer (100 mM, pH = 6. 8) was dispersed 
plus 10 μL α -glucosidase enzyme (1 U/mL) and 20 μL of varying con-
centrations of HF (0.0625, 0.125, 0.25, 0.5, and 1 mg/mL) were pre-
incubated at 37◦C for 15 min. Following preincubation, 50 μL of 5 mM 
P-NPG was added as a substrate and incubated further at 37◦C for 20 
mins. The reaction was brought to end by adding 50 μL Na2CO3 (0.1 M). 
The absorbance of the reaction mixture was measured at 405 nm using 
Multiplate Reader (Multiskan Thermo scientific, version 1.00.40, Van-
taa, Finland) and correlated to α-glucosidase inhibition. For the 
α-amylase inhibition experiment, α-amylase enzyme replaced α-gluco-
sidase enzyme, 1% starch solution was used in place of PNG and DNS in 
place of 0.1 M Na2CO3 in the mixtures. After the addition of 50 μL DNS, 
the reaction mixtures were boiled on a steam bath at 95◦C for 20 minutes 
for colour change. The same procedure was repeated for compounds A 
and B and their respective gold nanoparticles. Uninhibited solutions 
samples with AuNP were set up in parallel as control and each experi-
ment was performed in triplicates. The results were expressed as per-
centage inhibition calculated according to the formula, 
Inhibitory activity (%) = (A − B)/A × 100 
Fig. 7. a: FTIR of HF and HF-AuNPs 
b: FTIR of Compound A and Compound A-AuNPs 
c: FTIR of Compound B and CompoundB-AuNPs. 
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Where A = absorbances of uninhibited control and B = absorbances of 
test samples with inhibition agent. GraphPad Prism 5 statistical package 
(GraphPad Software, USA) was used for statistical analysis for the con-
centration of sample resulting in 50% inhibition of the α- glucosidase 
and α- amylase activities (IC50) respectively and results expressed in 
terms of mean ± standard deviation. 
3.6. Glucose uptake assay 
The method for measuring glucose uptake in mammalian cells based 
on the detection of 2-deoxyglucose-6-phosphate was performed ac-
cording to the manufacturer’s guidelines. When cells are exposed to 2- 
deoxyglucose (2DG), there are transported across the membrane and 
rapidly phosphorylated in the same manner as glucose. However, en-
zymes that further modify glucose-6-phosphate (G6P) cannot modify 
2DG6P, and thus a membrane-impermeable analyte accumulates in the 
cell. After a brief period of incubation, the acidic Stop Buffer is added to 
lyse cells, terminate uptake and destroy any NADPH. A high-pH buffer 
solution (Neutralization Buffer) is then added to neutralize the acid. A 
Detection reagent is added to the sample wells. Glucose-6-Phosphate 
Dehydrogenase oxidizes the deoxyglucose to 6-phosphodeoxygluconate 
and simultaneously reduces NADP+ to NADPH. The reductase uses 
NADPH to convert the proluciferin to luciferin, which is then used by 
Ultra-Glo™ Recombinant Luciferase to produce a luminescent signal 
that is proportional to the concentration of 2DG6P. 
The reaction mixtures were incubated at room temperature for 1 
hour. After 1 hour the cells were incubated with various concentrations 
Fig. 8. i: Stability-time studies of HF-AuNPs in different biogenic media 
ii: Stability-time studies of HB-AuNPs in different biogenic media 
iii: Stability-time studies of HA-AuNPs in different biogenic media. 
Table 1 
Inhibitory activities of HF, isolated compounds and biosynthesized nano-
particles on alpha-glucosidase and alpha-amylase.   
IC50 (μg/mL) 
Sample α-Glucosidase α-Amylase 
HF 27.3 ± 0.3 NA 
HF-AuNPs 391.5 ± 0.1 44.46 ± 3.3 
compound A 48.3 ± 0.1 NA 
compound A-AuNPs 173.3 ± 0.1 NA 
compound B 19.4 ± 0.3 25.13 ± 0.3 
compound B-AuNPs 40.0 ± 0.2 35.6 ± 0.1 
*NA = No activity 
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of each compound, the cells were washed with 100µl PBS. A volume of 
50 µL 1mM 2DG was added to each well and allowed to incubate for 10 
minutes. A volume of 25 µL stop buffer was added to each well and 
shaken briefly. Thereafter, 25 µL of neutralization buffer was added to 
each well and shaken briefly. Finally, a volume of 100 µL of reductase 
substrate mix was added and the plate was shaken briefly. The plate was 
then incubated at room temperature for 30 minutes and read on a plate 
reader at 15 minutes intervals for 2 hours. 
Fig. 7 indicates the relative glucose uptake for a given compound, 
compared to the control. The p-values in these graphs were calculated 
using an independent two-tailed T-test where 0.05 is the threshold for 
significance. 
Fig. 9. Relative glucose uptake of crude extract, compounds and nanoparticles; where the p-value is indicative of the statistical significance versus the control, using 
an independent two-tailed T-test. * p = 0.05, ** p = 0.005, ***p = 0.001. 
Fig. 10. Evaluation of the cytotoxicity of HF, compounds and nanoparticles on HaCaT cells. Cells were treated with HF and HF-AuNPs (A) HA and HA-AuNPs (B) HB 
and HB-AuNPs (C) at concentrations of 20 to 100 µg/mL and MTT assays were performed. Each bar shows the means ± standard error of means of three independent 
experiments performed in quadruplicates. 
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3.7. Cytotoxicity assay 
Cytotoxicity was assessed using the 3-[4,5-dimethylthiazol-2-yl]- 
2,5diphenyltetrazolium bromide colourimetric assay (MTT, Sigma). The 
MTT is a yellow tetrazolium salt that is reduced to purple formazan in 
living cells. Briefly, the HaCaT keratinocytes were plated in 96-well cell 
culture plates at a cell density of 5000 cells per well and incubated 
overnight to allow for attachment. The medium was thereafter replaced 
with a fresh medium containing increasing concentrations (20, 40, 60 80 
and 100 µg/mL) of HF, HA, HB, HF-AuNPs, HA-AuNPs and HB-AuNPs 
for 48 hours. Cells incubated with medium only served as control. 
After the 48 hours incubation, 10 μL of the MTT solution (5 mg/mL) was 
added to each well and the cells were incubated for an additional 4 hours 
at 37◦C. Thereafter, the resultant MTT crystals formed were solubilized 
in DMSO and absorbance of each well was read at 570 nm using a BMG 
Labtech Omega® POLARStar multimodal plate reader. The percentage 
cell viability was calculated using the formula below: 
% Cell Viability =
Absorbance of treated well
Absorbance of Untreated well
X 100 
The concentration required to kill 50% of the cells (IC50) was 
determined via a survival curve using GraphPad Prism6 software 
(GraphPad Software, San Diego, CA, USA). 
4. Results and discussion 
4.1. Isolation and identification of compounds 
Preliminary screening of H. foetidum extract for the synthesis of 
AuNPs [10], showed promising results, subsequently, it was subjected to 
purification steps to identify the compounds responsible for the reduc-
tion and stabilization of AuNPs. Chromatographic manipulation in 
parallel with NPs assay formation, two compounds were isolated. 
Structural elucidation of these compounds was completed by recording 
the 1H and 13C NMR data and compared with the literature [7,19,23,26, 
37]. The 1H and 13C NMR of compounds A and B discussed in the 
experimental session showed identical 1H and 13C NMR profiles with the 
same compounds reported previously. Compound B was identified as 
6`-methoxy-2`,4,4`-trihydroxy-chalcone (helichrysetin), and compound 
A as 6`-methoxy-2`,4-dihydroxy-chalcone-4`-O-β-D-glucopyranoside 
(helichrysin) a glycosylated form of HB (Fig. 1). These compounds were 
previously reported by [19] and [26] from the same plant [19,26]. 
However, the first record of these compounds from the Helichrysum 
genus shows that they were isolated from the flower extract of Heli-
chrysurn ps. aff. H. cooperi Harv. and the aerial part of H. heterolasium 
respectively [[7],37]. Compound B was later isolated from a flower 
extract of H. odoratissimum [23], and recently reported to induce 
apoptosis of cancer cells [16]. 
4.2. The interaction of the chalcones on the surface of gold nanoparticle 
The chemical structures of helichrysin and helichrysetin show the 
properties of Lewis bases due to the availability of a divalent oxygen 
atom, which serves as an electron donor/proton acceptor via the hy-
droxyl and carboxyl functional groups, as well as the presence of a 
conjugated double bonds system, as shown in Fig. 2. The oxidation/ 
reduction abilities of phenolic compounds are possible and depend on 
the reaction conditions [24]. In the case of chalcones, the extended 
chromophore supports the stability of the resulted –ve/+ve charges 
entity. From the practical point of view, the formation of the AuNPs is 
usually associated with the drop of the pH and the solution becomes 
acidic, under this condition and as given in scheme 1, the protonation of 
the oxygen atoms is very possible to form a positively charged stable 
system. The interaction of the positively charged with the negatively 
charged surface metal stabilize the NPs. This proposed mechanism is 
supported by the highly negative potential of the NPs as indicated from 
Zeta potential and the drop of the pH of the NPs solution 
4.2.1. Optical properties 
UV-Vis spectroscopy was used to confirm the formation of AuNPs. 
The solution of auric chloride, the total extracts and the two compounds, 
all had yellowish colours before synthesis. A visual colour change from 
yellowish to ruby red was the initial confirmation of AuNPs formation. 
This was characterized by intensely ruby red colours observed at 536 
nm, 540 and 546 nm bands for HF, compound A and compound B 
nanoparticles respectively (Fig. 3). These band absorptions were within 
the range reported for green mediated gold nanoparticles synthesis [25]. 
The absorption bands of compound A-AuNPs and compound B-AuNPs 
were almost similar suggestive of symmetrical sizes and shapes of their 
nanoparticles compared to HF-AuNPs. Worthy of note is that the for-
mation of the nanoparticles by the extract was instantaneous with 
higher intensity compared to the individual compounds. Abdel-Rauf et 
al. [1] reported a similar rapid formation of gold nanoparticles via an 
extract of Galaxaura elongate [1]. This could be due to the collective 
effect of more than one reducing agents present in HF which enhance the 
reducing ability of the total extract to yield a gold nanoparticle with a 
higher absorption peak compared to the others. Similar peaks for gold 
nanoparticles were reported by Thiphe et al. [33], which supports the 
phytochemical reduction of the auric chloride by the flavonoid con-
stituents of H. foetidum [33]. 
4.2.2. Morphology and size distribution 
HR-TEM technique gives information on the size, shape and crys-
tallinity of synthesized nanoparticles. The HR-TEM micrographs recor-
ded for the biosynthesized gold nanoparticles clearly show nanosized 
and non-agglomerated particles for compound B-AuNPs, A-AuNPs, and 
HF-AuNPs respectively (Fig. 4a–4c). Compound B-AuNPs and com-
pound A-AuNPs images revealed quasi-monodisperse shapes mostly 
hexagonal with a few spherical and triangular shapes, while HF-AuNPs 
exhibited varieties of shapes including spherical, triangular hexagonal, 
and rod shapes. Mean particles sizes from the histograms showed sizes in 
the range of 12.5±04.3, 6.7±1.68 and 2.02±0.53 nm for HF-AuNPs, 
compound A-AuNPs and compound B-AuNPs respectively. It is inter-
esting to note that the pure compounds enhanced the size reduction of 
the AuNPs formed when compared to the crude extract. The smaller 
sizes of compound A-AuNPs and compound B-AuNPs compared to HF- 
AuNPs can be attributed to the phenolic content of flavonoids that 
interface with the metal ions. Hence, it is suggestive that pure com-
pounds could proffer a better size-control of nanoparticles than using 
total extract in the biosynthesis of gold nanoparticle. The SAED patterns 
(Fig. 4aii – 4cii) indicated high crystallinity of all biosynthesized gold 
nanoparticles and it was in strong agreement with the XRD results. 
4.2.3. Dynamic light scattering by AuNPs 
Determination of zeta potential (ZP) of nanoparticles is necessary for 
nano-bio materials as it gives valuable information on the degree of 
stability of the particles in the colloidal system [13]. The zeta potential 
values range between +100 mV to -100 mV, however, values greater 
than +25 mV or less than -25 mV is considered to have a high degree of 
stability for low molecular weight samples [17]. Similarly, PDI 
measured provides information on the size distribution of particles and 
the level of uniformity or heterogeneity of particles sizes. PDI values less 
than 0.05 show high homogeneity of particles, values between 0.5-0.7 
are less uniform and above 0.7 is highly polydisperse [8]. To deter-
mine the stability of our nanoparticles between the interfacial double 
layers of particles surface charges, the disperse medium and the PDI, a 
Zetasizer that measures ZP and PDI based on dynamic light scattering 
was used. All samples gave moderate zeta potentials of -27.1, -24.3 and 
-24.1 mV for the total extract compound A and B respectively (Fig. 5i 
and 5ii) These values indicate that formed AuNP were less prone to 
aggregation with a slightly higher stability of HF-AuNPs than that of the 
compounds. This can be attributed to possible influence of the 
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polyphenols found in the total extract. Relatively high PDI values of 
0.440, 0.408 and 0.320 were obtained for HF-AuNPs, Compound 
A-AuNPs and Compound B-AuNPs respectively. This reflects the level of 
uniformity of sizes of nanoparticles as seen under HR-TEM. 
4.2.4. Crystallographic structure of green mediated nanoparticles 
In addition to SAED patterns, we further confirmed the high crys-
tallinity of all biosynthesized gold nanoparticles using X-ray diffraction 
measurement. Crystallographic reflection of all samples (Fig. 6) 
exhibited four main peaks centered at 38◦, 44◦, 65◦ and 76◦ (2θ) for HF- 
AuNPs and 38◦, 43◦, 64◦ and 77◦ (2θ) for both compound A-AuNPs and 
compound B-AuNPs (supplementary data). The peaks matched with 
JCP2 gold number 04-0784 for 38.185, 44.393, 64.578 and 77.549 
respectively. These values were attributed to crystallographic reflections 
that correspond to Miller indices of (111), (200), (220) and (311) planes 
of crystalline gold. Our result were in agreement with standard Bragg- 
Brentano geometry using Cu Kα radiation and corresponded to face- 
centred cubic metallic gold structure [12]. 
4.3. Vibrational spectroscopy 
FTIR spectra measurement showed functional groups in the constit-
uents of H. foetidum involved in the bioreduction of auric chloride. 
Functional groups of the extract and compounds matched with those of 
the nanoparticles indicating that the constituent of the plant capped the 
AuNPs (Fig. 7a–c). Peaks from HF, compound A, compound B and their 
gold nanoparticles were quite similar. However, a slight shift of some 
bands suggests the interaction of some functional groups with the sur-
face of the AuNPs [23]. For example, and as indicated in the figures, the 
most effect was observed for hydroxyl group stretching (~3337 cm− 1) 
and C=O stretch (1690-1697 cm− 1) which slightly changed from the 
parent compound and the AuNPs conjugates. The presence of bands at 
1600 cm− 1 (HF), 1594 cm− 1 (Compound A) and 1596 cm− 1 (Compound 
B) can be attributed to the C-C stretch of the aromatic (in-ring), which 
were slightly shifted in the reduced gold nanoparticles. Additionally, 
there was an enhancement to the band at ~3000 cm− 1, for the aromatic 
C-H stretches, also, the phenolic C-O stretching vibration located at 
1129 cm− 1, 1203 cm− 1 and 1216 cm− 1 in HF, compound A and B 
respectively. Bands were not shifted in the reduced AuNPs but appeared 
with different intensities. From the above discussion, the OH, C=O and 
aromatic rings could be the interaction points between the capping 
agents and the surface of Au NPs. 
4.4. Stability of AuNPs 
Fig. 8 represents the in-vitro stability-time studies for biocompati-
bility of the gold nanoparticles in proteinogenic amino acids (BSA, 
glycine, cysteine), NaCl solution, PBS at pH 7 and pH 9. This is to check 
the time duration for nanoparticles to retain their properties without 
decomposition in physiological systems. Stable absorption bands of the 
particles were recorded at 0, 24 and 48 hrs in different biogenic media 
on a UV-Vis spectrophotometer. Fig. 6i–ii revealed that a stable ab-
sorption maximum at 536±3 and 546±3 nm for HF-AuNPs and com-
pound B AuNPs respectively was maintained in all the media. However, 
compound A-AuNPs (Fig 6iii) was less stable after 24 hrs resulting in a 
broadening of bands in the media. This lower stability can be attributed 
to the availability of the glucose moiety in a metal-organic framework of 
compound A-AuNPs. It seems the glucose became unstable due to 
isomerization to fructose over gold nanoparticles in aqueous media of 
BSA, glycine and cysteine. A similar report was published for sodium 
titanate nanotubes where glucose in aqueous media rapidly isomerized 
to fructose [20]. Also, the lower stability of compound A-AuNPs can be 
attributed to the neutral to alkaline pH used, which facilitated possible 
isomerization and epimerization in a reversible reaction of glucose to 
fructose and mannose respectively [24]. 
4.5. Inhibition of α-glucosidase and α-amylase enzymes 
Enzymatic in vitro experiments for α-glucosidase and α-amylase in-
hibition at IC50 indicated higher activity for HF at 27.3 ± 0.3 μg /mL 
than HF-AuNPs at 391.5 ± 0.1 μg/mL, but no activity for α-amylase 
inhibition compared to HF-AuNPs (44.5 ± 0.1 μg/mL). Compound B and 
its AuNPs showed dual inhibitory potentials for both α-glucosidase and 
α-amylase enzymes, with HB (19.4 ± 0.3 μg /mL) slightly higher by two 
folds (40.0 ± 0.2 μg/mL) for α-glucosidase and nearly the same activity 
for α-amylase at 25.1± 0.3 μg/mL and 35.6 ± 0.1 μg/mL respectively, 
(Table 1). The aglycone form (compound B) showed higher activity of 
and its AuNPs than the glycosidic one (compound A). This is similar to 
the report of Hamid et al., [15] on the structure-activity-relationship of 
compounds from Tinospora crispa plant evaluated for α-glucosidase and 
α-amylase enzymes inhibition [15] However, compound A is the least 
active sample but displayed a higher activity for α-glucosidase than its 
nanoparticles. Both HA and its gold nanoparticles show no inhibition for 
α-amylase enzymes (Table 1). This may be attributed to the glycosidic 
bond attached to the chalcone structure that raised the inhibition 
threshold of the amylase enzyme. HF and HF-AuNPs displayed relatively 
strong activity probably as a result of synergy between chalcones present 
and their nanoparticles as demonstrated by compound B and its AuNPs. 
Despite the higher activities of HF constituents over their gold nano-
particles as drug candidates, the ability of the spleen and liver to 
recognize and remove drugs from systemic circulation may affect drug 
delivery. Badeggi et al. [3] reported gold nanoparticles capped by the 
total extract, fractions of procyanidins dimer and trimer isolated Leu-
cosidea sericea. In comparison, the AuNPs of the dimer was noted with 
higher inhibitory activity for α-amylase while the AuNPs of the trimer 
showed higher inhibition for α-glucosidase. Functionalized gold nano-
particles from HF constituents may be considered as an option for active 
drug targeting due to the inert and biocompatibility properties of gold. 
Overall, α-glucosidase activities of samples were in the following order: 
compound B > HF > compound B-AuNPs > compound A > compound 
A-AuNPs > HF-AuNPs, while for α-amylase activitieswere: compound B 
> compound B-AuNPs > HF-AuNPs. 
4.6. Glucose uptake activities of compounds and nanoparticles 
High blood glucose is known to be among the high-risk factors for 
cardiovascular diseases(CVD). Given the side effect of the prolonged use 
of synthetic drugs for the control of blood glucose, the aim of this study 
was to assess the activity of the crude extract, pure compounds and their 
nanoparticles on glucose uptake in mammalian cells. Fig. 9 shows that 
all the compounds, except for HF Crude and HB, seem to decrease the 
relative glucose uptake with significant p-values. A similar report by 
Rajarajeshwari show minimal glucose uptake by 3T3-Li adypocytes cells 
treated with gymnemic acid commonly found in Gymnema sylvestre and 
its synthesised gold nanoparticles (Rajarajeshwari et al., 2014). HF 
Crude increased relative glucose uptake significantly. However, this 
action may be due to a combination of compounds working synergisti-
cally to activate glucose ‘pick-up’ by insulin instead of a single com-
pound providing the action. This further confirms our result from 
carbohydrate enzyme inhibition and the potential of the total extract 
and the compound helichrysetin of H. foetidum as potential drug can-
didates for the management of diabetes conditions. 
4.7. Cytotoxicity results 
To determine the cytotoxicity of the plant extract, compounds and 
nanoparticles, the HaCaT keratinocytes from the human skin were used. 
This is a non-cancerous cell line and will be able to indicate the safety 
and toxicity of the extracts, compounds and nanoparticles. Following 
treatments, the MTT assay was performed and the results show that the 
plant extract, compounds and nanoparticles differentially induced 
cytotoxicity on the HaCaT cells at concentrations of 20 to 100 µg/mL 
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(Fig. 10). Previously, Maria et al. (Perde-schrepler et al., 2016) 
demonstrated that gold nanoparticles synthesized from polyphenol rich 
Cornelian Cherry fruits (Cornus mas) exhibited dose dependent toxicity 
on HaCaT and epidermoid carcinoma, A431 cells where the nano-
particles was less toxic to A431 cell than HACaT. In specifics, the IC50 
obtained for HF and HF-AuNPs was 49.04 µg/mL and 29.87 µg/mL 
respectively making them the most cytotoxic to the cells (Fig. 10A). In 
addition, the HA-AuNPs also induced cytotoxicity in the cells with IC50 
of 67.42 µg/mL while the compound HA showed slight toxicity to the 
cells (Fig. 10B). However, the compound HB, as well as the HB-AuNPs, 
had IC50s greater than 100 µg/mL (Fig. 10B). Taken together, findings 
from this study gave an indication of the cytotoxicity of the plant ma-
terial and compounds as well as their various nanoparticles. The com-
pound HA was least cytotoxic and could be explored further. 
5. Conclusion 
In this article, plant-mediated synthesis of gold nanoparticles with 
total extract and pure compounds from H. foetidum is reported for the 
first time. Through successive column chromatography, helichrysin and 
helichrysetin compounds were successfully isolated and characterized 
among other constituents. Extract and isolates showed promising 
application as both reducing and capping agents for biosynthesis gold 
nanoparticles through different physicochemical techniques. The pure 
compounds show a better effect in the size reduction of gold nano-
particles than the total extract and will be valuable in therapeutic and 
biomedical application. In addition, the use of pure compounds isolated 
from the total extract allows for a better understanding of the mecha-
nism of biosynthesis of gold nanoparticles and the systemic glucose 
utilization due to glucose phosphorylation and activities of glucose hy-
drolyzing enzymes in the cells. This study contributes to a possible novel 
blood glucose-lowering scafold developmed through the conjugation of 
metal NPs and natural chalcones. This conjugations have an inhibitory 
potential activities against α-amylase and α-glucosidase enzymes, and 
glucose uptake in vitro. It also paves way for further studies on animal 
studies to establish the use of H. foetidum and its gold nanoparticles 
against diabetes and glucose-induced oxidative stress. 
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